146 related articles for article (PubMed ID: 18758186)
21. High-dose mizoribine treatment for adolescents with systemic lupus erythematosus.
Nozu K; Iijima K; Kamioka I; Fujita T; Yoshiya K; Tanaka R; Nakanishi K; Yoshikawa N; Matsuo M
Pediatr Int; 2006 Apr; 48(2):152-7. PubMed ID: 16635174
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.
Nishi E; Kameda H; Ogawa H; Nagasawa H; Takei H; Okuyama A; Kurasawa T; Kondo T; Nishimura K; Shirai Y; Sakai R; Ito T; Takeuchi T; Amano K
Mod Rheumatol; 2013 Jan; 23(1):97-103. PubMed ID: 22526831
[TBL] [Abstract][Full Text] [Related]
23. Mizoribine requires individual dosing due to variation of bioavailability.
Fuke T; Abe Y; Hibino S; Takeshi M; Saito T; Sakurai S; Watanabe S; Murayama J; Itabashi K; Nakano Y
Pediatr Int; 2012 Dec; 54(6):885-91. PubMed ID: 23039376
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis.
Nomura A; Shimizu H; Kishimoto M; Suyama Y; Rokutanda R; Ohara Y; Yamaguchi K; Okada M
Lupus; 2012 Nov; 21(13):1444-9. PubMed ID: 22917589
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
26. Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.
Zhang M; Xing CY; Liu J
Rheumatol Int; 2013 Nov; 33(11):2737-42. PubMed ID: 23797779
[TBL] [Abstract][Full Text] [Related]
27. [Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].
Goto M; Ikeda M; Hataya H; Ishikura K; Hamasaki Y; Honda M
Nihon Jinzo Gakkai Shi; 2006; 48(4):365-70. PubMed ID: 16780106
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.
Chan TM; Tse KC; Tang CS; Lai KN; Li FK
Lupus; 2005; 14(4):265-72. PubMed ID: 15864912
[TBL] [Abstract][Full Text] [Related]
29. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Sasatomi Y; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
Clin Exp Nephrol; 2017 Dec; 21(6):961-970. PubMed ID: 27783276
[TBL] [Abstract][Full Text] [Related]
30. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
31. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
Buratti S; Szer IS; Spencer CH; Bartosh S; Reiff A
J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
[TBL] [Abstract][Full Text] [Related]
32. A Japanese multicenter study of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroid in renal transplantation (the fourth report).
Oshiro Y; Nakagawa K; Hoshinaga K; Aikawa A; Shishido S; Yoshida K; Asano T; Murai M; Hasegawa A
Transplant Proc; 2013 May; 45(4):1476-80. PubMed ID: 23726601
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
[TBL] [Abstract][Full Text] [Related]
36. The first year results of mizoribine/tacrolimus-based multitarget treatment for consecutive patients with lupus nephritis.
Kagawa H; Hiromasa T; Yamanaka R; Hayashi R; Tsunashima Y; Inoue T; Sada KE
Clin Exp Nephrol; 2018 Dec; 22(6):1371-1378. PubMed ID: 29948442
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[TBL] [Abstract][Full Text] [Related]
38. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
Uchino A; Tsukamoto H; Nakashima H; Yoshizawa S; Furugo I; Mitoma H; Oryoji K; Shimoda T; Niiro H; Tada Y; Yano T; Nonaka T; Oishi R; Akashi K; Horiuchi T
Clin Exp Rheumatol; 2010; 28(1):6-12. PubMed ID: 20346231
[TBL] [Abstract][Full Text] [Related]
39. A case report of steroid-resistant antineutrophil cytoplasmic antibody-related vasculitis successfully treated by mizoribine in a hemodialysis patient.
Tokunaga M; Tamura M; Kabashima N; Serino R; Shibata T; Matsumoto M; Miyamoto T; Miyazaki M; Furuno Y; Fujimatsu S; Muta T; Takeuchi M; Abe H; Okazaki M; Otsuji Y
Ther Apher Dial; 2009 Feb; 13(1):77-9. PubMed ID: 19379174
[TBL] [Abstract][Full Text] [Related]
40. Mizoribine therapy in a patient with lupus nephritis: the association between mizoribine concentration and peritoneal dialysis.
Kuroda T; Kobayashi D; Sato H; Oyanagi A; Wada Y; Murakami S; Nakano M; Narita I
Mod Rheumatol; 2010 Jun; 20(3):296-300. PubMed ID: 20082109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
